About nadprices
nadprices publishes what NAD+ sellers charge, by route, as a dated series. Every figure carries the day it was read, and every change is measured between two readings this site actually took. Anyone can publish today’s price; the record of what it was last month is the part that tells a buyer something.
Who writes it
Nate Corrigan’s background is pharmaceutical pricing and market access — tracking what things cost, who pays, and how quietly those numbers change. This site is a record rather than an opinion: every figure carries the date it was read, and every change is measured between two readings he actually took. Intro rates expire and sellers reprice without announcing it. A dated series is the only way a buyer can see that happen.
Nate Corrigan is a pen name. Writing under one is ordinary publishing practice, and it is disclosed here rather than left to be discovered. What sits behind it is real experience in pricing and market analysis — nothing clinical. He is not a physician, nurse, pharmacist, nurse practitioner, physician assistant or any other licensed clinician, and nothing on this site is medically reviewed. This site has no clinical review process, so it claims none.
What is here, and what is not
Here: prices, dates, and the qualifier attached to each figure, on the NAD+ price index. Not here: dosing advice, treatment recommendations, or any statement about whether NAD+ will do anything for you. Those questions belong with a clinician who knows your history. See the medical disclaimer.
How it is funded
Some of the sellers listed pay a commission when a reader buys after following a link. Which ones, how many, and what that does not buy are set out on the disclosure page, computed from the same data the index is built from. The method is on the editorial policy page.
Contact
contact@nadprices.com. A wrong figure is worth reporting; it will be fixed in public on the corrections page.
Index last read September 2026. 106 sellers tracked.